Abstract:The nucleosome remodeling and deacetylase (NuRD) complex plays a pivotal role in chromatin regulation and transcriptional repression. In mice, methyl-CpG binding domain 3 isoform C (MBD3C) interacts specifically with the histone H3 binding protein WD repeat-containing protein 5 (WDR5) and forms the WDR5-MBD3C/NuRD complex. Despite the functional significance of this interaction on embryonic stem cells gene regulation, the molecular mechanism underlying MBD3C recognition by WDR5 remains elusive. Here, we determined the crystal structure of WDR5 in complex with the peptide (residues 40-51) derived from the MBD3C protein at a resolution of 1.9 Å. Structural analysis revealed that MBD3C utilizes a unique binding mode to interact with WDR5, wherein MBD3C Arg43 and Phe47 are involved in recognizing the WDR5-interacting (WIN) site and Tyr191-related B site on the small surface of WDR5, respectively. Notably, the binding induces a ∼91° rotation of WDR5 Tyr191, generating the hydrophobic B site. Furthermore, mutation experiments combined with isothermal titration calorimetry (ITC) assays confirmed the importance of both Arg43 and Phe47 in mediating WDR5 binding affinity. By determining structures of various peptides bound to WDR5, we demonstrated that the WDR5 WIN site and B site can be concurrently recognized by WIN motif peptides containing ′′Arg-Cys/Ser-Arg-Val-Phe′′ consensus sequence. Overall, this study reveals the structural basis for the formation of the WDR5-MBD3C subcomplex and provides new insights into the recognition mode of WDR5 for the WIN motif. Moreover, these findings shed light on structural-based designs of WDR5-targeted anti-cancer small molecule inhibitors or peptide-mimic drugs.

Structural Studies of WDR5 in Complex with MBD3C WIN Motif Reveal a Unique Binding Mode

Structural basis for the specific recognition of methylated histone H3 lysine 4 by the WD-40 protein WDR5.

Histone H3 Recognition and Presentation by the WDR5 Module of the MLL1 Complex.

Crystal structure and functional characterization of the human RBM25 PWI domain and its flanking basic region.

WIN site inhibition disrupts a subset of WDR5 function

Overlapping characteristics of weak interactions of two transcriptional regulators with WDR5

Structural Plasticity of the TDRD3 Tudor Domain Probed by a Fragment Screening Hit

Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models

Identification and Validation of WDR5 WIN-site Ligands Via DNA-encoded Chemical Library Screening

Screening and Optimization of Phage Display Cyclic Peptides Against the WDR5 WBM Site

Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5

Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders

Structure-Based Design and Synthesis of Small Molecular Inhibitors Disturbing the Interaction of Mll1-Wdr5

WDR5 modulates cell motility and morphology and controls nuclear changes induced by a 3D environment

Molecular Insight into the SETD1A/B N-terminal Region and Its Interaction with WDR82

Structural insights into the recognition of histone H3Q5 serotonylation by WDR5

Structure-based design of ester compounds to inhibit MLL complex catalytic activity by targeting mixed lineage leukemia 1 (MLL1)-WDR5 interaction.

Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective

Computational Studies of Novel Aniline Pyrimidine WDR5-MLL1 Inhibitors: QSAR, Molecular Docking, and Molecular Dynamics Simulation

High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction.

Walking the Dna Methylation Tightrope: the Involvement of Intrinsically Disordered Regions of Transcription Factors